Drawing for 1907

USPTO serial 79223448

1907

Reviewed by CopyMark Law Group

Reg. 5563213Status 709
Filing date
Status date
Registration date
Sep 18, 2018
Examiner
SAUNDERS, ANDREA DAWN
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with 1907?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Dana Stewart-Mekdara

Dana Stewart-Mekdara GLOBAL TRADEMARKS, INC.505 S. Villa Real Drive, Suite 102Anaheim Hills, CA 92807UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Medicinal preparations for human purpose for treating blood circulation disease, heart disease, flu, sore throat, fever, digestive system diseases, wounds, gynecological diseases, oncological diseases, prostatitis; Pharmaceutical preparations for skin care; Pharmaceutical preparations for medical purposes, namely, the treatment of blood circulation disease, heart disease, flu, sore throat, fever, digestive system diseases, wounds, gynecological diseases, oncological diseases, prostatitis; medicinal tea; traditional Chinese medicinal preparations for treatment of anaphylactic reactions, respiratory diseases and cardiovascular diseases; Traditional Chinese medicinal preparations for treating blood circulation disease, heart disease, flu, sore throat, fever, digestive system diseases, wounds, gynecological diseases, oncological diseases, prostatitis; cachets for pharmaceutical purposes for treatment of blood circulation disease, heart disease, flu, sore throat, fever, digestive system diseases, wounds, gynecological diseases, oncological diseases, prostatitis; troche pills for treatment of anaphylactic reactions, respiratory diseases and cardiovascular diseases; Cardiotonics; dietetic foods adapted for medical useSECTION 71 - CANCELLED—
030Coffee; tea; sugar; honey; pastries; wheat flour; cooking saltSECTION 71 - CANCELLED—
044Health care; pharmaceutical advice; medical clinics; hospital services; convalescent homes; hairdressing salons; massagesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 4, 2025INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Apr 4, 2025C71TCANCELLED SECTION 71—
Sep 18, 2023REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Sep 19, 2019FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 1, 2019ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jan 1, 2019XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Jan 1, 2019XXCRGENERIC MADRID TRANSACTION CREATED—
Dec 18, 2018FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 18, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 3, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 3, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 13, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 25, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 25, 2018XAECEXAMINER'S AMENDMENT ENTERED—
May 25, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 25, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
May 25, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
May 14, 2018XAECEXAMINER'S AMENDMENT ENTERED—
May 14, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 14, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
May 14, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
May 14, 2018DMCCDATA MODIFICATION COMPLETED—
May 14, 2018ALIEASSIGNED TO LIE—
May 14, 2018XAECEXAMINER'S AMENDMENT ENTERED—
May 14, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 14, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
May 14, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
May 10, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 9, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 9, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 3, 2018RFNTREFUSAL PROCESSED BY IB—
Jan 13, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 13, 2018RFRRREFUSAL PROCESSED BY MPU—
Dec 30, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 27, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 26, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 26, 2017DOCKASSIGNED TO EXAMINER—
Dec 26, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 21, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance